DOI QR코드

DOI QR Code

Risk Factors for Early Recurrence of HBV-related Hepatocellular Carcinoma Meeting Milan Criteria after Curative Resection

  • Zhu, Wen-Jiang (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Huang, Chu-Ying (Department of Medical Oncology, West China Hospital of Sichuan University) ;
  • Li, Chuan (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Peng, Wei (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Wen, Tian-Fu (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Yan, Lv-Nan (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Li, Bo (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Wang, Wen-Tao (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Xu, Ming-Qing (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Yang, Jia-Yin (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University) ;
  • Jiang, Li (Liver Transplantation Center, Department of Liver Surgery, West China Hospital of Sichuan University)
  • Published : 2013.12.31

Abstract

Background: The prognosis of patients with hepatocellular carcinoma (HCC) after curative resection varies greatly. Few studies had investigated the risk factors for early recurrence (recurrence-free time ${\leq}$ 1 year) of hepatitis B virus (HBV)-related HCCs meeting Milan criteria. Methods: A retrospective analysis was performed on the 224 patients with HCC meeting Milan criteria who underwent curative liver resection in our center between February 2007 and March 2012. The overall survival (OS) rate, recurrence-free survival (RFS) rate and risk factors for early recurrence were analyzed. Results: After a median follow-up of 33.3 months, HCC reoccurred in 105 of 224 patients and 32 died during the period. The 1-, 3- and 5-year OS rates were 97.3%, 81.6% and 75.6% respectively, and the 1-, 3- and 5-year RFS rates were 73.2%, 53.7% and 41.6%. Cox regression showed alpha-fetoprotein (AFP) > 800 ng/ml (HR 2.538, 95% CI 1.464-4.401, P=0.001), multiple tumors (HR 2.286, 95% CI 1.123-4.246, P=0.009) and microvascular invasion (HR 2.518, 95% CI 1.475-4.298, P=0.001) to be associated with early recurrence (recurrence-free time ${\leq}$ 1-year) of HCC meeting Milan criteria. Conclusions: AFP > 800 ng/ml, multiple tumors and microvascular invasion are independent risk factors affecting early postoperative recurrence of HCC. In addition resection appears capable of replacing liver transplantation in some situations with safety and a better outcome.

References

  1. Baccarani U, Benzoni E, Adani GL, et al (2008). Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transpl Int, 21, 247-54. https://doi.org/10.1111/j.1432-2277.2007.00597.x
  2. Belghiti J, Cortes A, Abdalla EK, et al (2003). Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg, 238, 885-92. https://doi.org/10.1097/01.sla.0000098621.74851.65
  3. Cherqui D, Laurent A, Mocellin N, et al (2009). Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg, 250, 738-46. https://doi.org/10.1097/SLA.0b013e3181bd582b
  4. Cheung TT, Poon RT, Yuen WK, et al (2013). Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a singlecenter experience. Ann Surg, 257, 506-11. https://doi.org/10.1097/SLA.0b013e31827b947a
  5. Fan ST, Poon RT, Yeung C, et al (2011). Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg, 98, 1292-300. https://doi.org/10.1002/bjs.7583
  6. Fuks D, Dokmak S, Paradis V, et al (2012). Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology, 55, 132-40. https://doi.org/10.1002/hep.24680
  7. Hasegawa K, Kokudo N, Imamura H, et al (2005). Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg, 242, 252-9. https://doi.org/10.1097/01.sla.0000171307.37401.db
  8. Huang ZY, Liang BY, Xiong M, et al (2012). Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol, 19, 2515-25. https://doi.org/10.1245/s10434-012-2269-7
  9. Kim BK, Han KH, Park YN, et al (2008). Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol, 97, 246-52. https://doi.org/10.1002/jso.20953
  10. Kim H, Park MS, Park YN, et al (2009). Preoperative radiologic and postoperative pathologic risk factors for early intrahepatic recurrence in hepatocellular carcinoma patients who underwent curative resection. Yonsei Med J, 50, 789-95. https://doi.org/10.3349/ymj.2009.50.6.789
  11. Koniaris LG, Levi DM, Pedroso FE, et al (2011). Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg, 254, 527-37. https://doi.org/10.1097/SLA.0b013e31822ca66f
  12. Kuang DM, Zhao Q, Wu Y, et al (2011). Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol, 54, 948-55. https://doi.org/10.1016/j.jhep.2010.08.041
  13. Lee KK, Kim DG, Moon IS, et al (2010). Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol, 101, 47-53. https://doi.org/10.1002/jso.21415
  14. Lei J, Wang WT, Yan LN (2013). Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria. J Gastrointest Surg, 17, 1440-6. https://doi.org/10.1007/s11605-013-2229-y
  15. Lim KC, Chow PK, Allen JC, et al (2012). Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg, 99, 1622-9. https://doi.org/10.1002/bjs.8915
  16. Majno PE, Sarasin FP, Mentha G, Hadengue A (2000). Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology, 31, 899-906. https://doi.org/10.1053/he.2000.5763
  17. Mano Y, Shirabe K, Yamashita Y, et al (2013). Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg, 258, 301-5. https://doi.org/10.1097/SLA.0b013e318297ad6b
  18. Mazzaferro V, Regalia E, Doci R, et al (1996). Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 334, 693-9. https://doi.org/10.1056/NEJM199603143341104
  19. Minagawa M, Makuuchi M, Takayama T, Kokudo N (2003). Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg, 238, 703-10. https://doi.org/10.1097/01.sla.0000094549.11754.e6
  20. Ochiai T, Sonoyama T, Ichikawa D, et al (2004). Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol, 130, 197-202. https://doi.org/10.1007/s00432-003-0533-8
  21. Park YK, Kim BW, Wang HJ, et al (2009). Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. Transplant Proc, 41, 1691-7. https://doi.org/10.1016/j.transproceed.2008.07.146
  22. Poon RT, Fan ST, Ng IO, et al (2000). Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 89, 500-7. https://doi.org/10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O
  23. Poon RT, Fan, ST, Lo CM, et al (2002). Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg, 235, 373-82. https://doi.org/10.1097/00000658-200203000-00009
  24. Ren J, Zheng C, Feng G, et al (2009). Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci, 29, 198-201. https://doi.org/10.1007/s11596-009-0212-3
  25. Roayaie S, Bassi D, Tarchi P, et al (2011). Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol, 55, 346-50. https://doi.org/10.1016/j.jhep.2010.11.026
  26. Sakata J, Shirai Y, Wakai T, et al (2008). Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol, 34, 900-5. https://doi.org/10.1016/j.ejso.2008.01.031
  27. Sala, M, Llovet JM, Vilana R, et al (2004). Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology, 40, 1352-60. https://doi.org/10.1002/hep.20465
  28. Sumie S, Kuromatsu R, Okuda K, et al (2008). Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol, 15, 1375-82. https://doi.org/10.1245/s10434-008-9846-9
  29. Toyosaka A, Okamoto E, Mitsunobu M, et al (1996). Pathologic and radiographic studies of intrahepatic metastasis in hepatocellular carcinoma; the role of efferent vessels. HPB Surg, 10, 97-103. https://doi.org/10.1155/1996/75210
  30. Ueno S, Sakoda M, Kubo F, et al (2009). Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg, 16, 359-66. https://doi.org/10.1007/s00534-009-0069-7
  31. Wang CC, Iyer SG, Low JK, et al (2009). Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol, 16, 1832-42. https://doi.org/10.1245/s10434-009-0448-y
  32. Yao FY, Ferrell L, Bass NM, et al (2001). Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 33, 1394-403. https://doi.org/10.1053/jhep.2001.24563
  33. Zhao WC, Fan LF, Yang N, et al (2013). Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma. Eur J Surg Oncol, 39, 858-64. https://doi.org/10.1016/j.ejso.2013.04.003
  34. Zheng SS, Xu X, Wu J, et al (2008). Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation, 85, 1726-32. https://doi.org/10.1097/TP.0b013e31816b67e4
  35. Zhou YM, Yang JM, Li B, et al (2010). Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int, 9, 33-7.

Cited by

  1. Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4545
  2. Clinical Study of Hepatectomy Combined with Jianpi Huayu Therapy for Hepatocellular Carcinoma vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5951
  3. Influence of Clinically Significant Portal Hypertension on Hepatectomy for Hepatocellular Carcinoma: a Meta-analysis vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1649
  4. PKM2 Regulates Hepatocellular Carcinoma Cell Epithelial-mesenchymal Transition and Migration upon EGFR Activation vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.1961
  5. Schedule-Dependent Effects of Kappa-Selenocarrageenan in Combination with Epirubicin on Hepatocellular Carcinoma vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3651
  6. Can gamma-glutamyl transferase levels contribute to a better prognosis for patients with hepatocellular carcinoma? vol.8, pp.3, 2014, https://doi.org/10.5582/ddt.2014.01025
  7. Hepatoprotective Effects of Curcumin Against Diethyl Nitrosamine Induced Hepatotoxicity in Albino Rats vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.103
  8. Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3479
  9. High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma vol.94, pp.21, 2015, https://doi.org/10.1097/MD.0000000000000810
  10. Histological expression of methionine adenosyl transferase (MAT) 2A as a post-surgical prognostic surrogate in patients with hepatocellular carcinoma vol.117, pp.5, 2018, https://doi.org/10.1002/jso.24994
  11. Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection vol.13, pp.1, 2018, https://doi.org/10.1186/s13027-018-0192-7